Compare Stocks → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:KENNASDAQ:KODNASDAQ:PWM Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeKENKenon$21.67+1.0%$24.34$17.64▼$30.65$1.16B1.4570,765 shs12,240 shsKODKodiak Sciences$3.33-2.6%$5.21$1.37▼$9.80$179.58M2.15985,299 shs327,652 shsPWMPrestige Wealth$1.14+8.6%$1.39$1.01▼$31.88$9.45MN/A63,429 shs12,124 shs7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceKENKenon+0.60%+1.59%-14.14%-10.75%-18.44%KODKodiak Sciences-2.63%-14.40%-46.72%-10.96%-32.86%PWMPrestige Wealth+8.57%+1.79%-22.97%-33.33%+113,999,900.00%top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution…MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationKENKenon0.662 of 5 stars0.04.01.70.02.30.00.6KODKodiak Sciences2.8176 of 5 stars2.90.00.04.61.23.31.3PWMPrestige WealthN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceKENKenonN/AN/AN/AN/AKODKodiak Sciences1.71Reduce$5.5065.17% UpsidePWMPrestige WealthN/AN/AN/AN/ACurrent Analyst RatingsLatest KOD, CFE, EUZ, KEN, and PWM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/4/2024KODKodiak SciencesUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$3.00 ➝ $5.004/1/2024KODKodiak SciencesBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderweight ➝ Underweight$2.00 ➝ $3.00(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookKENKenon$692M1.69N/AN/A$38.42 per share0.56KODKodiak SciencesN/AN/AN/AN/A$5.07 per shareN/APWMPrestige Wealth$350K29.31N/AN/AN/A∞Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateKENKenon-$235.98M-$4.42N/A∞N/A-34.10%-10.82%-5.80%6/3/2024 (Estimated)KODKodiak Sciences-$260.49M-$4.96N/AN/AN/AN/A-80.20%-46.17%5/20/2024 (Estimated)PWMPrestige Wealth-$1.04MN/A0.00∞N/AN/AN/AN/AN/ALatest KOD, CFE, EUZ, KEN, and PWM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/28/2024Q4 2023KODKodiak Sciences-$0.86-$1.13-$0.27-$1.13N/AN/A3/26/2024Q4 2023KENKenonN/A$0.11+$0.11$0.11N/A$151.00 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthKENKenon$3.8017.54%N/AN/A 1 YearsKODKodiak SciencesN/AN/AN/AN/AN/APWMPrestige WealthN/AN/AN/AN/AN/ALatest KOD, CFE, EUZ, KEN, and PWM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/26/2024KENKenon--$3.8010.5%4/5/20244/8/20244/15/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioKENKenon0.663.053.05KODKodiak SciencesN/A6.936.93PWMPrestige Wealth0.0312.8012.80OwnershipInstitutional OwnershipCompanyInstitutional OwnershipKENKenon13.38%KODKodiak Sciences89.06%PWMPrestige Wealth7.68%Insider OwnershipCompanyInsider OwnershipKENKenon0.14%KODKodiak Sciences45.40%PWMPrestige WealthN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableKENKenon32553.89 million53.81 millionOptionableKODKodiak Sciences11652.51 million28.67 millionOptionablePWMPrestige Wealth49.00 millionN/ANot OptionableKOD, CFE, EUZ, KEN, and PWM HeadlinesSourceHeadlineAdapting the lessons of retail to wealth managementpwmnet.com - April 23 at 9:53 AMPrestige Wealth (PWM) stock has gone parabolic but faces risksinvezz.com - March 7 at 8:14 AMPrestige Wealth Stock (NASDAQ:PWM), Short Interest Reportbenzinga.com - February 23 at 8:35 AMLendingClub among financials gainers, New York Community Bancorp in losersseekingalpha.com - January 31 at 12:47 PMCANO, VIEW and CDT among mid-day moversmsn.com - December 8 at 1:43 PMPrestige Wealth reports H1 resultsmsn.com - December 4 at 8:56 AMPrestige Wealth Inc. Announces First Half of Fiscal Year 2023 Financial Resultsfinance.yahoo.com - December 1 at 6:50 PMB. Riley leads financials gainers, Noah Holdings in losersmsn.com - November 30 at 2:27 PMSoFi Technologies, Upstart, Cipher Mining among financials losersmsn.com - November 16 at 1:50 PMB. Riley Financial among financials gainers, CPI Card Group in losersmsn.com - November 7 at 1:16 PMPrestige Wealth Inc PWMmorningstar.com - October 31 at 6:39 PMeHealth, Universal Insurance, Cipher Mining among financials moversmsn.com - October 30 at 1:57 PMPWM Prestige Wealth Inc.seekingalpha.com - July 29 at 9:05 PMPrestige Wealth Inc (PWM)investing.com - July 25 at 6:41 AMIs Prestige Wealth Inc (PWM) Stock a Good Investment?aaii.com - July 19 at 10:09 AMWhat's Going On With Prestige Wealth (PWM) Stock?msn.com - July 17 at 2:52 PMPWM - Prestige Wealth Inc.ca.finance.yahoo.com - July 14 at 11:46 PMPrestige Wealth Inc.wsj.com - July 13 at 2:42 PMPre-market Movers: HCTI, CVKD, SILK, ELOX, PRFX…markets.businessinsider.com - July 12 at 8:58 AMPrestige Wealth Shares Halted On Circuit Breaker To The Upside, Stock Now Down -1.15%benzinga.com - July 10 at 9:53 PMWhat's Going On With Prestige Weath (PWM) Stock Monday?benzinga.com - July 10 at 4:53 PMPrestige Wealth Inc. Announces Closing of Initial Public Offeringfinance.yahoo.com - July 10 at 4:53 PMPrestige Wealth stock soars again, to trade 480% above IPO price in 3 daysmsn.com - July 10 at 4:53 PMWhat's Going On With Prestige Wealth (PWM) Stock Monday?msn.com - July 10 at 4:53 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioFoot Locker Builds Up Another Head of Steam; Gains ImminentMarch 28, 2024 10:58 AMView Foot Locker Builds Up Another Head of Steam; Gains Imminent5 Stocks in the Current Bull Market with Upside to ComeApril 5, 2024 10:14 AMView 5 Stocks in the Current Bull Market with Upside to ComeDisney Stock Catches 3 Upgrades In a Single WeekMarch 28, 2024 10:27 AMView Disney Stock Catches 3 Upgrades In a Single WeekCan Tyson Win from Repealing Its No-Antibiotic Chicken Pledge?April 10, 2024 7:55 AMView Can Tyson Win from Repealing Its No-Antibiotic Chicken Pledge?All Headlines Company DescriptionsKenonNYSE:KENKenon Holdings Ltd., through its subsidiaries, operates as an owner, developer, and operator of power generation facilities in Israel, the United States, and internationally. It operates through OPC Power Plants, CPV Group, and ZIM segments. The company engages in the generation and supply of electricity and energy; development, construction, and management of solar and wind energy, and conventional natural gas-fired power plants; and provision of container liner shipping services. It also operates a fleet of 150 vessels. Kenon Holdings Ltd. was incorporated in 2014 and is based in Singapore. Kenon Holdings Ltd. operates as a subsidiary of Ansonia Holdings Singapore B.V.Kodiak SciencesNASDAQ:KODKodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.Prestige WealthNASDAQ:PWMPrestige Wealth Inc., through its subsidiaries, provides wealth management and asset management services. It assists its clients in identifying and purchasing wealth and asset management products. The company offers its services primarily for high net worth and ultra-high net worth individuals, including business owners, executives, heirs of rich families, and other affluent individuals in Asia primarily in the mainland China or Hong Kong. The company was incorporated in 2018 and is based in Central, Hong Kong. Prestige Wealth Inc. is a subsidiary of Prestige Financial Holdings Group Limited. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
